| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
29,950,000 |
| Market
Cap: |
92.85(M) |
| Last
Volume: |
42,300 |
Avg
Vol: |
41,992 |
| 52
Week Range: |
$2.38 - $5.22 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Computer Hardware |
| Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.3 |
| Insider 3/6 Months : 6.9 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Anixa Biosciences is a biotechnology company developing therapies and vaccines that are focused on unmet needs in oncology and infectious disease. Co.'s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer and the discovery and development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. Co.'s vaccine programs include the development of a vaccine against triple negative breast cancer as well other forms of breast cancer and a vaccine against ovarian cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
15,000 |
50,000 |
272,845 |
| Total Buy Value |
$0 |
$46,600 |
$153,300 |
$766,522 |
| Total People Bought |
0 |
2 |
3 |
4 |
| Total Buy Transactions |
0 |
2 |
7 |
29 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-10-30 |
2025-07-29 |
2025-01-28 |
2024-01-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Baskies Arnold M |
Director |
|
2026-01-28 |
4 |
B |
$3.04 |
$30,400 |
D/D |
10,000 |
135,000 |
2.39 |
- |
|
Titterton Lewis H Jr |
Director |
|
2025-12-15 |
4 |
OE |
$2.92 |
$46,720 |
D/D |
16,000 |
969,334 |
|
- |
|
Kumar Amit |
Chief Executive Officer |
|
2025-10-30 |
4 |
D |
$4.06 |
$687,922 |
D/D |
(169,439) |
610,486 |
|
- |
|
Kumar Amit |
Chief Executive Officer |
|
2025-10-30 |
4 |
OE |
$2.92 |
$584,000 |
D/D |
200,000 |
779,925 |
|
- |
|
Titterton Lewis H Jr |
Director |
|
2025-07-31 |
4 |
B |
$3.08 |
$30,800 |
D/D |
10,000 |
953,334 |
2.39 |
71% |
|
Kumar Amit |
Chief Executive Officer |
|
2025-07-30 |
4 |
B |
$3.16 |
$15,800 |
D/D |
5,000 |
579,925 |
2.74 |
52% |
|
Baskies Arnold M |
Director |
|
2025-07-18 |
4 |
B |
$3.39 |
$16,950 |
D/D |
5,000 |
125,000 |
2.39 |
26% |
|
Titterton Lewis H Jr |
Director |
|
2025-07-11 |
4 |
B |
$3.14 |
$31,400 |
D/D |
10,000 |
943,334 |
2.39 |
34% |
|
Kumar Amit |
Chief Executive Officer |
|
2025-07-11 |
4 |
B |
$3.15 |
$15,750 |
D/D |
5,000 |
574,925 |
2.74 |
34% |
|
Kumar Amit |
Chief Executive Officer |
|
2025-06-04 |
4 |
B |
$2.85 |
$28,500 |
D/D |
10,000 |
569,925 |
2.74 |
62% |
|
Baskies Arnold M |
Director |
|
2025-01-28 |
4 |
B |
$2.82 |
$14,100 |
D/D |
5,000 |
120,000 |
2.39 |
-1% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-24 |
4 |
B |
$3.00 |
$3,000 |
D/D |
1,000 |
933,334 |
2.31 |
-1% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-23 |
4 |
B |
$2.91 |
$5,820 |
D/D |
2,000 |
932,334 |
2.39 |
-3% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-22 |
4 |
B |
$3.01 |
$6,020 |
D/D |
2,000 |
930,334 |
2.39 |
-3% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-21 |
4 |
B |
$2.59 |
$15,540 |
D/D |
6,000 |
928,334 |
2.39 |
-9% |
|
Titterton Lewis H Jr |
Director |
|
2025-01-17 |
4 |
B |
$2.57 |
$25,700 |
D/D |
10,000 |
922,334 |
2.39 |
8% |
|
Kumar Amit |
Chief Executive Officer |
|
2025-01-15 |
4 |
B |
$2.23 |
$95,890 |
D/D |
43,000 |
559,925 |
2.74 |
10% |
|
Catelani Michael |
President, COO, & CFO |
|
2025-01-15 |
4 |
B |
$2.15 |
$19,971 |
D/D |
9,289 |
44,500 |
2.74 |
10% |
|
Titterton Lewis H Jr |
Director |
|
2024-10-22 |
4 |
OE |
$2.58 |
$41,200 |
D/D |
16,000 |
912,334 |
|
- |
|
Titterton Lewis H Jr |
Director |
|
2024-07-31 |
4 |
B |
$3.23 |
$18,023 |
D/D |
5,580 |
896,334 |
2.39 |
-10% |
|
Titterton Lewis H Jr |
Director |
|
2024-07-30 |
4 |
B |
$3.06 |
$66,237 |
D/D |
21,646 |
890,754 |
2.39 |
3% |
|
Baskies Arnold M |
Director |
|
2024-07-26 |
4 |
B |
$3.09 |
$15,450 |
D/D |
5,000 |
115,000 |
2.39 |
6% |
|
Titterton Lewis H Jr |
Director |
|
2024-07-26 |
4 |
B |
$3.03 |
$23,331 |
D/D |
7,700 |
869,108 |
2.39 |
6% |
|
Titterton Lewis H Jr |
Director |
|
2024-07-25 |
4 |
B |
$2.81 |
$2,237 |
D/D |
796 |
861,408 |
2.31 |
15% |
|
Titterton Lewis H Jr |
Director |
|
2024-06-14 |
4 |
B |
$2.68 |
$10,720 |
D/D |
4,000 |
860,612 |
2.39 |
21% |
|
154 Records found
|
|
Page 1 of 7 |
|
|